Furthermore, CXCL10 is highly enriched in MS CSF (41), indicating that additional targeting of CXCR3 could be crucial to completely suppress the brain-homing capability of Th17.1 cells. The gene discussed is CXCR3; the disease is myeloid sarcoma.